Low risk of serological cross-reactivity between dengue and COVID-19

Mem Inst Oswaldo Cruz. 2020:115:e200225. doi: 10.1590/0074-02760200225. Epub 2020 Aug 14.

Abstract

In the near future, the overlap of Coronavirus disease 2019 (COVID-19) and dengue epidemics is a concrete threat in tropical regions. Co-epidemics of COVID-19 and dengue could be an overwhelming challenge for health systems in low- and middle-income countries. In this work, we investigated potential serological cross-reactions between COVID-19 and dengue patients. Among 32 COVID-19 positive sera, no positive Dengue virus (DENV) IgG/IgM results were observed. On the other hand, one false-positive result was observed among 44 DENV-positive sera tested for COVID-19 antibodies with each of the two rapid tests used. Further data on accuracy of COVID-19 diagnostic test are urgently warranted.

MeSH terms

  • Antibodies, Viral / immunology*
  • Betacoronavirus / immunology
  • COVID-19
  • Coronavirus Infections / immunology*
  • Cross Reactions*
  • Dengue / immunology*
  • Dengue Virus / immunology
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Immunoglobulin G / immunology
  • Immunoglobulin M / immunology
  • Pandemics
  • Pneumonia, Viral / immunology*
  • SARS-CoV-2

Substances

  • Antibodies, Viral
  • Immunoglobulin G
  • Immunoglobulin M